Conference News

Real-World nAMD Treatment Patterns Reveal Cost of Switching

Analysis of Medicare claims show increases in drug-related expenditures after initial low-cost therapy.

Share

  • 1

    The Retina World Congress gathers experts in retina and vitreous

  • 2

    A platform for knowledge sharing and discussions on advancements in retinal care

  • 3

    Aims to enhance patient care through collaboration and innovation

  • 4

    Promotes networking opportunities for retina specialists and researchers

  • 5

    Focuses on insights and innovations in retinal care

Original Source(s)

Real-World nAMD Treatment Patterns Reveal Cost of Switching

Analysis of Medicare claims show increases in drug-related expenditures after initial low-cost therapy.

  • by Jim Gallagher, senior managing editor

  • May 1, 2025

  • 5 min

Related Content

Understanding Protocol AO, the DRCR Retina Network’s Study of Home OCT

A conversation with Christina Y. Weng, MD, MBA

PRISM Trial Update Presented at RWC

Mark Barakat, MD, provided an update on the PRISM clinical trial for 4D-150 (4DMT) for wet AMD at the Retina World Congress meeting in Fort Lauderdale.

Migaldendranib May Move the Needle in AMD, DME

Michael A. Singer, MD, shares early phase 2 data supporting D-4517.2 as a safe and effective subcutaneous therapy, reducing injection burden and preserving vision.